Dallara, president of Medtronic’s diabetes business, discussed the segment’s turnaround and why she sees a benefit in ...

Researchers writing in The Lancet review breakthroughs in type 1 diabetes treatment, from immunotherapies that delay onset to ...

The draft EASD/ADA Type 1 Diabetes Management Guidance document adds new information about diagnosing T1D in adults as well ...

The carbs, protein, and fat found in your favorite slice can be a recipe for diabetes complications. Learn how to enjoy a slice and stay in your healthy zone.

Dutch device company ViCentra has raised $85m to boost its Kaleido insulin patch pump’s entry onto the US market. According to the company, initial commercial uptake for the pump in Germany, France, ...

Medtronic has obtained a pair of major green lights from the FDA for its flagship insulin pump—opening up the MiniMed 780G to adults with Type 2 diabetes in the U.S. and allowing it to connect with a ...

Led by new investor Innovation Industries, with matching contributions from existing investors, Partners in Equity and Invest-NL, the $85M round also drew support from EQT Life Sciences and Health ...

In a medical first, researchers report that they have implanted CRISPR-edited pancreas cells into a person with type 1 diabetes. The cells pumped out sugar-regulating insulin for months — without the ...

Persistent high blood sugar in diabetes, despite insulin use, often stems from insulin resistance, where cells fail to respond effectively to the hormone. Factors like excess weight, inactivity, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA has approved an expanded indication for the ...